Vaccinex, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Vaccinex, Inc. (VCNX) had Deferred Tax Assets, Operating Loss Carryforwards of $82.34 million as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-04-15
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $82.34M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $78.53M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $75.80M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards $73.80M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2024-12-31 | $82.34M 10-K · filed 2025-04-15 |
| 2023-12-31 | $78.53M 10-K · filed 2025-04-15 |
| 2022-12-31 | $75.80M 10-K/A · filed 2024-04-25 |
| 2021-12-31 | $73.80M 10-K · filed 2023-03-31 |
| 2020-12-31 | $67.74M 10-K · filed 2022-03-31 |
| 2019-12-31 | $60.47M 10-K · filed 2021-03-31 |
| 2018-12-31 | $52.36M 10-K · filed 2020-03-09 |
| 2017-12-31 | $45.06M 10-K · filed 2019-03-13 |